CARBOHYDRATE METABOLISM PARAMETERS IN CASE OF ADMINISTRATION OF ZINC-CONTAINING MEDICATIONS IN COMPLEX TREATMENT OF DIABETES MELLITUS

O.A. Olenovych, N.V. Pashkovska

Анотація


In order to improve treatment efficacy for patients with diabetes mellitus the possibility of administration of Zinkit (Woerwag Pharma, Germany) in a complex treatment program was studied. According to the results of a complex assessment of glycemia control indices in patients with diabetes mellitus 3 weeks after the enrollment to the study it was revealed, that additional to hypoglycemic therapy administration of zinc-containing medication not only promoted reliable decrease of fasting and 2-hours postprandial blood glucose level, but also approached glycemia indices to the goal levels of a satisfactory control of
diabetes, provided significant reduction of HbA1C level by
6,8 % of its initial level.

Повний текст:

PDF

Посилання

  • Поки немає зовнішніх посилань.


Copyright (c) 2017 O.A. Olenovych, N.V. Pashkovska

Технічний редактор журналу, к.мед.н. М. Степанченко, 2015-2017